Showing results (1501-1510 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|December 15, 2018
The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphateEvelien A W Smits, José A Soetekouw, Ebel H E Pieters, et al.
Investigational New Drugs|December 21, 2018
A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinomaTheodoros N Teknos, J Grecula, A Agrawal, et al.
Investigational New Drugs|June 21, 2022
Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinomaJuanyan Liao, Hui Guan, Min Yu, et al.
Investigational New Drugs|June 29, 2022
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumorsTodd Bauer, Byong Chul Cho, Rebecca Heist, et al.
Investigational New Drugs|July 7, 2022
3D cell cultures, as a surrogate for animal models, enhance the diagnostic value of preclinical in vitro investigations by adding information on the tumour microenvironment: a comparative study of new dual-mode HDAC inhibitorsSofia I Bär, Bernhard Biersack, Rainer Schobert
Investigational New Drugs|June 30, 2022
Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignanciesYu Sunakawa, Keishiro Takahashi, Osamu Kawaguchi, et al.
Investigational New Drugs|July 6, 2022
Two novel piperidones induce apoptosis and antiproliferative effects on human prostate and lymphoma cancer cell linesRisa Mia Swain, Lisett Contreras, Armando Varela-Ramirez, et al.
Investigational New Drugs|November 17, 2020
A decision process for drug discovery in retinoblastomaMaría Belen Cancela, Santiago Zugbi, Ursula Winter, et al.
Investigational New Drugs|January 6, 2021
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemiaRenata Scopim-Ribeiro, João Agostinho Machado-Neto, Christopher A Eide, et al.
Investigational New Drugs|January 7, 2021
Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysisHan Li, Jinsheng Xu, Yaling Bai, et al.
Pageof 372